Study of Safety and Efficacy of HLX01+MTX in Patients With Rheumatoid Arthritis
Status:
Completed
Trial end date:
2020-09-11
Target enrollment:
Participant gender:
Summary
To compare the efficacy between the HLX01 group and the placebo group through the proportion
of subjects meeting the ACR20 improvement criteria for remission